• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Dec 15, 1998; 102(12): 2115–2125.
PMCID: PMC509166

Evidence for altered synthesis of type II collagen in patients with osteoarthritis.


There is evidence to suggest that the synthesis of type II collagen is increased in osteoarthritis (OA). Using an immunoassay, we show that the content of the C-propeptide of type II procollagen (CPII), released extracellularly from the newly synthesized molecule, is directly related to the synthesis of this molecule in healthy and osteoarthritic articular cartilages. In OA cartilage, CPII content is often markedly elevated (mean 7.6-fold), particularly in the mid and deep zones, reaching 29.6% of the content in newborn. Synthesis is also directly related to total collagen II content in OA, suggesting its importance in maintaining collagen content and cartilage structure. The release of CPII from cartilage is correlated directly with cartilage content. However, the increase in CPII in OA cartilage is not reflected in serum, where a significant reduction is observed. Together these studies provide evidence for alterations in procollagen II synthesis in vivo in patients with OA.

Full Text

The Full Text of this article is available as a PDF (870K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mayne R. Cartilage collagens. What is their function, and are they involved in articular disease? Arthritis Rheum. 1989 Mar;32(3):241–246. [PubMed]
  • Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, Poole AR. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest. 1994 Apr;93(4):1722–1732. [PMC free article] [PubMed]
  • Kempson GE, Muir H, Pollard C, Tuke M. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta. 1973 Feb 28;297(2):456–472. [PubMed]
  • Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders (first of two parts). N Engl J Med. 1979 Jul 5;301(1):13–23. [PubMed]
  • Peltonen L, Halila R, Ryhänen L. Enzymes converting procollagens to collagens. J Cell Biochem. 1985;28(1):15–21. [PubMed]
  • Kujawa MJ, Weitzhandler M, Poole AR, Rosenberg L, Caplan AI. Association of the C-propeptide of type II collagen with mineralization of embryonic chick long bone and sternal development. Connect Tissue Res. 1989;23(2-3):179–199. [PubMed]
  • Poole AR, Pidoux I, Reiner A, Choi H, Rosenberg LC. Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol. 1984 Jan;98(1):54–65. [PMC free article] [PubMed]
  • Lee ER, Smith CE, Poole R. Ultrastructural localization of the C-propeptide released from type II procollagen in fetal bovine growth plate cartilage. J Histochem Cytochem. 1996 May;44(5):433–443. [PubMed]
  • Hinek A, Reiner A, Poole AR. The calcification of cartilage matrix in chondrocyte culture: studies of the C-propeptide of type II collagen (chondrocalcin). J Cell Biol. 1987 May;104(5):1435–1441. [PMC free article] [PubMed]
  • Alini M, Matsui Y, Dodge GR, Poole AR. The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif Tissue Int. 1992 Apr;50(4):327–335. [PubMed]
  • Månsson B, Carey D, Alini M, Ionescu M, Rosenberg LC, Poole AR, Heinegård D, Saxne T. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest. 1995 Mar;95(3):1071–1077. [PMC free article] [PubMed]
  • Lee ER, Matsui Y, Poole AR. Immunochemical and immunocytochemical studies of the C-propeptide of type II procollagen in chondrocytes of the growth plate. J Histochem Cytochem. 1990 May;38(5):659–673. [PubMed]
  • Nimni ME. Collagen: structure, function, and metabolism in normal and fibrotic tissues. Semin Arthritis Rheum. 1983 Aug;13(1):1–86. [PubMed]
  • Spanheimer RG, Peterkofsky B. A specific decrease in collagen synthesis in acutely fasted, vitamin C-supplemented, guinea pigs. J Biol Chem. 1985 Apr 10;260(7):3955–3962. [PubMed]
  • Spanheimer RG, Bird TA, Peterkofsky B. Regulation of collagen synthesis and mRNA levels in articular cartilage of scorbutic guinea pigs. Arch Biochem Biophys. 1986 Apr;246(1):33–41. [PubMed]
  • Tyler JA, Benton HP. Synthesis of type II collagen is decreased in cartilage cultured with interleukin 1 while the rate of intracellular degradation remains unchanged. Coll Relat Res. 1988 Sep;8(5):393–405. [PubMed]
  • Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 1971 Apr;53(3):523–537. [PubMed]
  • Lippiello L, Hall D, Mankin HJ. Collagen synthesis in normal and osteoarthritic human cartilage. J Clin Invest. 1977 Apr;59(4):593–600. [PMC free article] [PubMed]
  • Thompson RC, Jr, Oegema TR., Jr Metabolic activity of articular cartilage in osteoarthritis. An in vitro study. J Bone Joint Surg Am. 1979 Apr;61(3):407–416. [PubMed]
  • Rizkalla G, Reiner A, Bogoch E, Poole AR. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest. 1992 Dec;90(6):2268–2277. [PMC free article] [PubMed]
  • Aigner T, Stöss H, Weseloh G, Zeiler G, von der Mark K. Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol. 1992;62(6):337–345. [PubMed]
  • Aigner T, Bertling W, Stöss H, Weseloh G, von der Mark K. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest. 1993 Mar;91(3):829–837. [PMC free article] [PubMed]
  • Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest. 1989 Feb;83(2):647–661. [PMC free article] [PubMed]
  • Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997 Apr 1;99(7):1534–1545. [PMC free article] [PubMed]
  • Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest. 1995 Dec;96(6):2859–2869. [PMC free article] [PubMed]
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. [PubMed]
  • Poole AR, Ionescu M, Swan A, Dieppe PA. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis. J Clin Invest. 1994 Jul;94(1):25–33. [PMC free article] [PubMed]
  • Pal S, Tang LH, Choi H, Habermann E, Rosenberg L, Roughley P, Poole AR. Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res. 1981 Feb;1(2):151–176. [PubMed]
  • Burleigh MC, Barrett AJ, Lazarus GS. Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem J. 1974 Feb;137(2):387–398. [PMC free article] [PubMed]
  • Choi HU, Tang LH, Johnson TL, Pal S, Rosenberg LC, Reiner A, Poole AR. Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem. 1983 Jan 10;258(1):655–661. [PubMed]
  • Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980 Mar 1;102(2):344–352. [PubMed]
  • Van der Rest M, Rosenberg LC, Olsen BR, Poole AR. Chondrocalcin is identical with the C-propeptide of type II procollagen. Biochem J. 1986 Aug 1;237(3):923–925. [PMC free article] [PubMed]
  • Niyibizi C, Wu JJ, Eyre DR. The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral-disc tissue. Biochim Biophys Acta. 1987 Dec 18;916(3):493–499. [PubMed]
  • Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, Aebi M, Alini M. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 1996 Aug 15;98(4):996–1003. [PMC free article] [PubMed]
  • Hollander AP, Heathfield TF, Liu JJ, Pidoux I, Roughley PJ, Mort JS, Poole AR. Enhanced denaturation of the alpha (II) chains of type-II collagen in normal adult human intervertebral discs compared with femoral articular cartilage. J Orthop Res. 1996 Jan;14(1):61–66. [PubMed]
  • Aigner T, Vornehm SI, Zeiler G, Dudhia J, von der Mark K, Bayliss MT. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. 1997 Mar;40(3):562–569. [PubMed]
  • Eyre DR, McDevitt CA, Billingham ME, Muir H. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J. 1980 Jun 15;188(3):823–837. [PMC free article] [PubMed]
  • Burton-Wurster N, Hui-Chou CS, Greisen HA, Lust G. Reduced deposition of collagen in the degenerated articular cartilage of dogs with degenerative joint disease. Biochim Biophys Acta. 1982 Sep 17;718(1):74–84. [PubMed]
  • Miller DR, Lust G. Accumulation of procollagen in the degenerative articular cartilage of dogs with osteoarthritis. Biochim Biophys Acta. 1979 Mar 7;583(2):218–231. [PubMed]
  • Matyas JR, Adams ME, Huang D, Sandell LJ. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis Rheum. 1995 Mar;38(3):420–425. [PubMed]
  • Matyas JR, Adams ME, Huang D, Sandell LJ. Major role of collagen IIB in the elevation of total type II procollagen messenger RNA in the hypertrophic phase of experimental osteoarthritis. Arthritis Rheum. 1997 Jun;40(6):1046–1049. [PubMed]
  • Carey DE, Alini M, Ionescu M, Hyams JS, Rowe JC, Rosenberg LC, Poole AR. Serum content of the C-propeptide of the cartilage molecule type II collagen in children. Clin Exp Rheumatol. 1997 May-Jun;15(3):325–328. [PubMed]
  • Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M. Procollagen II C-propeptide in joint fluid: changes in concentration with age, time after knee injury, and osteoarthritis. J Rheumatol. 1996 Oct;23(10):1765–1769. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...